skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Download your infographic below

Access this infographic which focuses on Gilead’s drug Remdesivir which currently shows the greatest promise for the likelihood of approval as a possible treatment to effectively treat the virus. The infographic highlights the drug summary and profile, the number of patients in each trial phase, and the history of events that have moved this product through the development process.

Take a look at the Top Ten Companies also in the race and where their products are in the clinical trial development phase.

Data for this infographic has been extracted from Informa Pharma Intelligence’s products Biomedtracker –tracking drugs pipeline, upcoming milestones, companies, and deals – and their impact on the markets, and Pharmaprojects - offering end-to-end tracking of the global pharma R&D pipeline from bench to patient, including company development trends, global development status, and therapeutic class status.

The Race to Find a COVID-19 Treatment